Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Kewaunee Scientific Corporation (KEQU) had Revenue of $240.47M for the most recently reported fiscal year, ending 2025-04-30.

Quarterly Annual

Figures for fiscal year ending 2025-04-30

Income Statement Financials
Revenue	$240.47M
Net Income	$11.40M
Cost of Goods Sold	$171.62M
Gross Profit	$68.86M
Operating Expenses	$222.71M
Operating Income	$17.76M
Non-Operating Income/Expense	$-2.97M
Pre-Tax Income	$14.79M
Normalized Pre-Tax Income	$14.79M
Income after Taxes	$11.58M
Income from Continuous Operations	$11.58M
Consolidated Net Income/Loss	$11.58M
Normalized Income after Taxes	$11.58M
EBIT	$17.76M
EBITDA	$22.74M
Weighted-Average Shares Outstanding (Basic)	2.86M
Weighted-Average Shares Outstanding (Diluted)	2.98M
Earnings per Share (EPS) (Basic)	$3.98
Earnings per Share (EPS) (Diluted)	$3.83
Balance Sheet Financials
Current Assets	$118.36M
Property, Plant, and Equipment	$23.17M
Long-Term Assets	$76.29M
Total Assets	$194.65M
Current Liabilities	$53.71M
Long-Term Debt	$60.73M
Long-Term Liabilities	$74.70M
Total Liabilities	$128.41M
Common Equity	$66.25M
Tangible Shareholders Equity	$35.93M
Shareholders Equity	$66.25M
Common Shares Outstanding	2.84M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$14.78M
Cash Flow from Investing Activities	$-30.90M
Cash Flow from Financial Activities	$7.41M
Beginning Cash	$25.94M
End Cash	$17.16M
Increase/Decrease in Cash	$-8.77M
Stock-Based Compensation	$1.44M
Common Stock Dividends Paid	$-0.26M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.20
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.48
Debt to Equity Ratio	0.99
Gross Margin	28.63%
Operating Margin	7.39%
EBIT Margin	7.39%
EBITDA Margin	9.45%
Pre-Tax Profit Margin	6.15%
Profit Margin	4.74%
Free Cash Flow	$12.62M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.24
Inventory Turnover	5.22
Receiveable Turnover	3.85
Days Sales in Receivables	94.69
Return on Equity	17.49%
Return on Tangible Equity	32.24%
Return on Assets	5.95%
Return on Investments	9.12%
Book Value Per Share	$23.33
Free Cash Flow per Share	$4.24
Operating Cash Flow per Share	$4.96

Data from Zacks Investment Research, Inc.